Mesenchymal stromal cell administration promotes macrophage-mediated bile duct regeneration
Regenerative Therapy · 2026-03 · 31 · 101065
DOI: 10.1016/j.reth.2026.101065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Therapy, 2026-03. Verfasst von Takanori Igarashi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niiga…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Kaken Pharmaceutical Co Ltd.
Abstract (Originalsprache)
Introduction
Mesenchymal stromal cell (MSC) therapy is used in cirrhosis models of chronic hepatocellular damage and represents a novel therapeutic approach for liver regeneration. However, no studies have examined MSC therapy for bile duct injury and its effects on bile duct regeneration. This study aimed to elucidate the mechanism underlying bile duct regeneration by establishing a regeneration model and administering MSCs.
Methods
A model of bile duct regeneration was developed by feeding mice a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-containing diet to induce bile duct injury, followed by a normal diet to promote bile duct regeneration. MSCs were administered concurrently with the normal diet, and the livers were analyzed after 2 days. An experimental system was also developed in which clodronate liposomes were administered alongside MSCs to eliminate the influence of macrophages.
Results
MSC administration significantly increased the rate of body weight gain and the liver-to-body weight ratio on day 2 after the change to a normal diet. Immunostaining revealed an increase in the number of CK19+ cholangiocytes. The numbers of Hnf4α+ and Sox9+ cells were significantly elevated in the MSC-treated group. Flow cytometric analysis of liver lymphocytes showed a significant increase in the number of Ly6C- macrophages in the MSC-treated group. Furthermore, analysis of liver lymphocyte populations and cap analysis of gene expression revealed alterations in the immune response and macrophage-related genes, whereas macrophage removal during MSC treatment abolished the bile duct regenerative effects observed with MSC treatment.
Conclusions
Macrophages play a crucial role in bile duct regeneration, and MSC administration has regenerative effects. This approach has potential as a novel treatment modality for bile duct injuries.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.
- Department of General Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.
- Department of Gastroenterology and Hepatology, Yamanashi University Graduate School of Medical and Dental Sciences, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
Förderung
- Japan Society for the Promotion of Science
- Kaken Pharmaceutical Co Ltd
Zitieren
APA
Igarashi, T., Kimura, N., Abe, H., Yoshida, T., Watanabe, Y., Kamimura, H., Sakamaki, A., Yokoo, T., Kamimura, K., Tsuchiya, A., & Terai, S. (2026). Mesenchymal stromal cell administration promotes macrophage-mediated bile duct regeneration. Regenerative Therapy, 31, 101065. https://doi.org/10.1016/j.reth.2026.101065
Vancouver
Igarashi T, Kimura N, Abe H, Yoshida T, Watanabe Y, Kamimura H, et al. Mesenchymal stromal cell administration promotes macrophage-mediated bile duct regeneration. Regenerative Therapy. 2026;31:101065. doi:10.1016/j.reth.2026.101065
BibTeX
@article{Igarashi2026,
author = {Igarashi, Takanori and Kimura, Naruhiro and Abe, Hiroyuki and Yoshida, Tomoaki and Watanabe, Yusuke and Kamimura, Hiroteru and Sakamaki, Akira and Yokoo, Takeshi and Kamimura, Kenya and Tsuchiya, Atsunori and Terai, Shuji},
title = {Mesenchymal stromal cell administration promotes macrophage-mediated bile duct regeneration},
journal = {Regenerative Therapy},
year = {2026},
volume = {31},
pages = {101065},
doi = {10.1016/j.reth.2026.101065}
}
EUVIMED